BOPA 2023 | Enhancing awareness of prostate cancer amongst primary healthcare providers

Diana Matthews, Velindre Cancer Centre, Cardiff, UK, describes current unmet needs in prostate cancer, including an increased rate of metastatic prostate cancer at diagnosis despite an overall decrease of prostate cancer cases. Increasing awareness amongst various clinicians is vital to reduce late presentations of prostate cancer. Genetic testing additionally needs to be improved, so newly approved therapies such as olaparib can be administered to the right group of patients. This interview took place at the 26th Annual British Oncology Pharmacy Association (BOPA) Symposium in Newport, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.